Lymphoma and Radiation

50 %
50 %
Information about Lymphoma and Radiation
Health & Medicine

Published on May 29, 2013

Author: doctorbobm

Source: slideshare.net

Description

The use of radiation therapy in the treatment of Lymphoma

Lymphoma and RadiationRobert Miller MDwww.aboutcancer.com

New Cancer Cases Per YearLymphoma is # 7 in men and # 6 in women

Cancer Deaths Per YearLymphoma is # 9 in men and # 7 in women

Median Age of People Diagnosed in2005- 2009All Sites: 66yHodgkins 38yNon-Hodgkins 66y

Lymphomas in 2013Hodgkin 9,290 (12%)Non-Hodgkin’s 69,740 (88%)Thomas Hodgkin 1798-1866

What isLymphoma?Lymphoma is a cancer that arises from a mutation by acell that is part of the lymphatic system.The lymphatic system includes the lymphocytes, lymphnodes and other parts of the lymphatic system includethe spleen, thymus, tonsils and bone marrow

What is aLymphocyte?A lymphocyte is a type of white blood cell in theimmune system, can be divided into large lymphocytesand small lymphocytes. Large granular lymphocytesinclude natural killer cells (NK cells). Small lymphocytesconsist of T cells and B cells.

Stem cellsdifferentiate intoseveral kinds ofblood cell within thebone marrowB cells mature into Blymphocytes in thebone marrow while Tcells migrate to andmature in thethymus.Then they enter thecirculation andperipheral lymphoidorgans (e.g. thespleen and lymphnodes) where theysurvey for invadingpathogens and/ortumor cells.

Cluster of differentiation (cluster of designation) (oftenabbreviated as CD) is commonly used as cell markersin immunophenotyping allowing cells to be definedbased on what molecules are present on theirsurface.

Circulating LymphocytesT lymphocytes 70%B lymphocytes 23%NK Cells 7%B cell make up only 23% of circulatinglymphocytes but account for 90% of lymphoma

Prognosis and Treatment forLymphoma Stage Histologic type◦ Non-Hodgkin’s or Hodgkin◦ B cell or T cell◦ Indolent of aggressive Other risk factors of advanced disease

Specific Prognosis Factors forHodgkin Wide mediastinal mass ( > .33) Bulky mass (10 cm or bigger) Multiple site, ESR > 50, B symptoms Age over 45, male gender Anemia or low albumin

Types of LymphomaAll malignancies are based on theoriginal cell that ‘goes bad’ or mutatesSince the immune system is so complexthe number of distinct lymphomas isnow immense and growing

Classification of NHL (Non-Hodgkins)

Classification of NHL (Non-Hodgkins)

Classification of NHL (Non-Hodgkins)

Classification of HodgkinsLymphocyte Predominant (LPHL) (5%)Classical Hodgkin’s (CHL) (95%)- Nodular Sclerosis (NSHL)- Mixed Cellularity (MCCHL)- Lymphocyte-depleted (LDCHL)- Lymphoxcyte-rich (LRCHL)

NCCN.org

Treatment for NHL LymphomaMost patients are treated with drugtherapy (chemotherapy or moleculartargeted therapy).So many different types of lymphomathe options range from no initialtherapy for slow growing (low grade orindolent) lymphomas to very intensivechemotherapy and bone marrowtransplant for aggressive lymphomas

Cluster of differentiation (cluster of designation) (oftenabbreviated as CD) is commonly used as cell markersin immunophenotyping allowing cells to be definedbased on what molecules are present on theirsurface.

CD 20: Normal B Cells and 90% of B Cell NHLbut not on Stem Cells or Plasma CellsPluripotentStem CellLymphoidStem CellPre-B Cell B Cell ActivatedB CellPlasmacell

Rituximab AntibodyAntibody bindingReceptorAntibodyComplexCD20B CellLymphocyte

After Rituximab binds to the CD20 receptor on the BCell it leads to death of the cell by multiplemechanisms

ToposomeraseinhibitorAlkylationagentsAntimetabolitesTaxanesVinka alkaloidsDividing CancerCellTraditional Chemotherapy and Mechanism of Action

Rituxan, Zevalin, BexxarMylotargCampathVelcadeGleevacSprycelHerceptinErbituxVectibixAvastinNexavarSutentTykerbTarcevaIressaSolid TumorsHematologic MalignanciesTargetedTherapies

Zevalin, is a monoclonalantibody radioimmunotherapy usesantibody to which a radioactiveisotope of yttrium-90Once the antibodyattached to the CD20receptor or the B cell theradioactivity form yttriumkills the cancer cell

Bexxar is anti-CD20 monoclonal antibody bound to theradionuclide iodine-131 which emits both beta and gammaradiation

Role for Conventional Radiationin NHL? SLL localized Follicular Lymphoma early stage Gastric MALT (H. pylori negative) Nongastirc MALT localized Mantle Cell, early stage Diffuse Large B Cell (esp bulky) Cutaneous B-Cell Peripheral T-Cell Mycosis Fungoides Extranodal NK-T

Radiation Technique for NHL Volume is IF (involved field) just thenode involved based on original size Generally Low Dose

Low Dose Radiation for NHL

Is there still a role for radiation in thetreatment of Hodgkin Lymphoma?Henry Kaplan atStanford pioneered theuse of the linearaccelerator andradiation treatment ofHodgkins in the 1960and 1970’s

Role for Radiation inHodgkin’s? Lymphocyte-predominant early stagemay need radiation only Early stages use involved site (IS)radiation combined with limitedchemoRx (usually ABVD) or moreintensive chemoRx alone with noradiation High Risk (bulky or unfavorable) addradiation to chemoRx

Radiation Doses forHodgkin’s

1370 patients with newly diagnosed early-stageHodgkins lymphoma with a favorable prognosis toone of four treatment groups (German HD10 Trial)N Engl J Med 2010; 363:640-652Chemo IF XRT 8 YearSurvivalABVD X 4 30Gy 94.4%ABVD X 4 20Gy 94.7%ABVD X 2 30Gy 93.6%ABVD X 2 20Gy 95.1%

Long Term Risks of RadiationRadiationfieldTissue damage (espthe lungs, heart orthyroid or bonemarrow) and causingnew cancers (espbreast or leukemia)

Long Term Health Risk after chemoradiationfor early stage Hodgkin’s

ABVD Alone versus Radiation-Based Therapy (SNI)in Limited-Stage Hodgkins LymphomaHD6 TrialN Engl J Med 2012; 366:399-408

Lymphoma and RadiationRobert Miller MDwww.aboutcancer.com

Add a comment

Related presentations

Related pages

Lymphoma Therapy : Radiotherapy

Information on radiation therapy / radiotherapy treatment for lymphoma
Read more

Radiation therapy for non-Hodgkin lymphoma

Radiation therapy uses high-energy rays to kill cancer cells. When radiation is used to treat non-Hodgkin lymphoma, it’s most often done with ...
Read more

Radiation Therapy for Lymphoma and Leukemia - WebMD

Radiation therapy is the use of high-dose X-rays to destroy cancer cells. Radiation therapy is often used for the treatment of cancer, such as ...
Read more

Facts About Lymphoma - RT Answers - Answers to Your ...

First described by Dr. Thomas Hodgkin in 1832, Hodgkin’s lymphoma was incurable until radiation therapy began to cure patients fifty years ago.
Read more

Radiation Therapy for Non-Hodgkin Lymphoma | CTCA

Learn about radiation therapy for non-Hodgkin lymphoma. CTCA uses targeted radiation treatments to destroy lymphoma cells and help relieve NHL-related pain.
Read more

Radiation Therapy for Hodgkin's Lymphoma - CancerConnect ...

Overview Radiation therapy is an important treatment modality for patients with Hodgkin’s disease. However, radiation therapy is usually not the sole ...
Read more

About radiotherapy for non Hodgkin lymphoma | Cancer ...

About radiotherapy for non Hodgkin lymphoma. Radiotherapy uses high energy rays to kill cancer cells. Radiotherapy is often used as a local treatment.
Read more

Hodgkin's lymphoma - Wikipedia, the free encyclopedia

Hodgkin's lymphoma, (HL ... For Hodgkin's lymphomas, radiation oncologists typically use external beam radiation therapy (sometimes shortened to EBRT or XRT).
Read more

Radiation Therapy | Leukemia and Lymphoma Society

Radiation therapy is sometimes used to destroy non-Hodgkin lymphoma (NHL) cells that have accumulated in one area of the body.
Read more

Radiation Therapy for Hodgkin Lymphoma | CTCA

Radiation therapy for Hodgkin lymphoma. We use radiation therapy to destroy lymphoma cells, to prevent the cells from spreading, and/or to relieve pain or ...
Read more